Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 May;23(5):523–528. doi: 10.1111/j.1365-2125.1987.tb03087.x

Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man.

R J Unwin, T Reed, S Thom, J Calam, W S Peart
PMCID: PMC1386187  PMID: 3297124

Abstract

The mechanisms of the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) are unclear. Rabbit studies suggest that VIP-induced tachycardia is largely beta-adrenoceptor mediated, but that the renin response may be partially prostaglandin-dependent. To examine the relative importance of prostaglandins and reflex sympathetic activation in the haemodynamic and renin responses to VIP infusion in man, we completed two randomised single-blind crossover studies in two groups of six healthy male volunteers (aged 24-35 years). We recorded the effects of indomethacin and propranolol pretreatment on VIP-related changes in heart rate (HR), blood pressure (BP), forearm vascular resistance (FVR), plasma renin activity (PRA), plasma noradrenaline (PNA) and plasma arginine vasopressin (AVP) concentrations. Intravenous VIP (calculated dose: 6 pmol kg-1 min-1) produced cutaneous flushing, increased HR and PRA, decreased FVR, but did not alter mean arterial BP or AVP levels. Indomethacin (375 mg over 3 days) lowered basal PRA and propranolol (circa 40 mg i.v. over 60 min) decreased resting HR and increased FVR. Although indomethacin and propranolol reduced the absolute rise in PRA and HR, respectively, during VIP infusion, the percentage changes were no different from control. Neither drug altered the flush response to VIP and propranolol did not affect the fall in FVR. We conclude that the measured cardiovascular responses to VIP infusion in man are probably direct and do not involve a significant contribution from reflex sympathetic stimulation, nor prostaglandin release.

Full text

PDF
523

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brayden J. E., Halpern W., Brann L. R. Biochemical and mechanical properties of resistance arteries from normotensive and hypertensive rats. Hypertension. 1983 Jan-Feb;5(1):17–25. doi: 10.1161/01.hyp.5.1.17. [DOI] [PubMed] [Google Scholar]
  2. Calam J., Dimaline R., Peart W. S., Singh J., Unwin R. J. Effects of vasoactive intestinal polypeptide on renal function in man. J Physiol. 1983 Dec;345:469–475. doi: 10.1113/jphysiol.1983.sp014989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Calam J., Dimaline R., Peart W. S., Unwin R. Studies on the renin response to vasoactive intestinal polypeptide (VIP) in the conscious rabbit. Br J Pharmacol. 1983 Sep;80(1):13–15. doi: 10.1111/j.1476-5381.1983.tb11043.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Christophe J., Waelbroeck M., Chatelain P., Robberecht P. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Peptides. 1984 Mar-Apr;5(2):341–353. doi: 10.1016/0196-9781(84)90232-8. [DOI] [PubMed] [Google Scholar]
  5. Coltart D. J., Shand D. G. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man. Br Med J. 1970 Sep 26;3(5725):731–734. doi: 10.1136/bmj.3.5725.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davies I. B., Sever P. S., Rosenthal T. Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol. Br J Clin Pharmacol. 1979 Jul;8(1):49–51. doi: 10.1111/j.1365-2125.1979.tb05908.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fahrenkrug J., Emson P. C. Vasoactive intestinal polypeptide: functional aspects. Br Med Bull. 1982 Sep;38(3):265–270. doi: 10.1093/oxfordjournals.bmb.a071771. [DOI] [PubMed] [Google Scholar]
  8. Friesen S. R. Tumors of the endocrine pancreas. N Engl J Med. 1982 Mar 11;306(10):580–590. doi: 10.1056/NEJM198203113061005. [DOI] [PubMed] [Google Scholar]
  9. Güllner H. G., Lake C. R., Bartter F. C., Kafka M. S. Effect of inhibition of prostaglandin synthesis on sympathetic nervous system function in man. J Clin Endocrinol Metab. 1979 Oct;49(4):552–556. doi: 10.1210/jcem-49-4-552. [DOI] [PubMed] [Google Scholar]
  10. Jaffe B. M., Kopen D. F., DeSchryver-Kecskemeti K., Gingerich R. L., Greider M. Indomethacin-responsive pancreatic cholera. N Engl J Med. 1977 Oct 13;297(15):817–821. doi: 10.1056/NEJM197710132971508. [DOI] [PubMed] [Google Scholar]
  11. Lightman S. L., Unwin R. J., Graham K., Dimaline R., McGarrick G. Vasoactive intestinal polypeptide stimulation of prolactin release and renin activity in normal man and patients with hyperprolactinaemia: effects of pretreatment with bromocriptine and dexamethazone. Eur J Clin Invest. 1984 Dec;14(6):444–448. doi: 10.1111/j.1365-2362.1984.tb01211.x. [DOI] [PubMed] [Google Scholar]
  12. McAinsh J., Baber N. S., Smith R., Young J. Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. Br J Clin Pharmacol. 1978 Aug;6(2):115–121. doi: 10.1111/j.1365-2125.1978.tb00835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McGiff J. C., Malik K. U., Terragno N. A. Prostaglandins as determinants of vascular reactivity. Fed Proc. 1976 Oct;35(12):2382–2387. [PubMed] [Google Scholar]
  14. Ottesen B., Hansen B., Fahrenkrug J., Fuchs A. R. Vasoactive intestinal peptide (VIP) stimulates oxytocin and vasopressin release from the neurohypophyis. Endocrinology. 1984 Oct;115(4):1648–1650. doi: 10.1210/endo-115-4-1648. [DOI] [PubMed] [Google Scholar]
  15. Peart W. S. Renin release. Gen Pharmacol. 1978;9(2):65–72. doi: 10.1016/0306-3623(78)90001-0. [DOI] [PubMed] [Google Scholar]
  16. Pettinger W. A., Campbell W. B., Keeton K. Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat. Circ Res. 1973 Jul;33(1):82–86. doi: 10.1161/01.res.33.1.82. [DOI] [PubMed] [Google Scholar]
  17. Polak J. M., Pearse A. G., Garaud J. C., Bloom S. R. Cellular localization of a vasoactive intestinal peptide in the mammalian and avian gastrointestinal tract. Gut. 1974 Sep;15(9):720–724. doi: 10.1136/gut.15.9.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Porter J. P., Said S. I., Ganong W. F. Vasoactive intestinal peptide stimulates renin secretion in vitro: evidence for a direct action of the peptide on the renal juxtaglomerular cells. Neuroendocrinology. 1983 May;36(5):404–408. doi: 10.1159/000123488. [DOI] [PubMed] [Google Scholar]
  19. ROBERTSON J. I., PEART W. S., ANDREWS T. M. The mechanism of facial flushes in the carcinoid syndrome. Q J Med. 1962 Jan;31:103–123. [PubMed] [Google Scholar]
  20. Said S. I. Vasoactive intestinal polypeptide (VIP): current status. Peptides. 1984 Mar-Apr;5(2):143–150. doi: 10.1016/0196-9781(84)90197-9. [DOI] [PubMed] [Google Scholar]
  21. Sever P. S., Osikowska B., Birch M., Tunbridge R. D. Plasma-noradrenaline in essential hypertension. Lancet. 1977 May 21;1(8021):1078–1081. doi: 10.1016/s0140-6736(77)92335-2. [DOI] [PubMed] [Google Scholar]
  22. Ueda H., Kaneko Y., Takeda T., Ikeda T., Yagi S. Observation on the mechanism of renin release by hydralazine in hypertensive patients. Circ Res. 1970 Oct;27(Suppl):201–206. [PubMed] [Google Scholar]
  23. Unwin R. J., Calam J., Peart W. S., Dimaline R., Lightman S. L. Vipoma and watery diarrhea. N Engl J Med. 1982 Aug 5;307(6):377–378. doi: 10.1056/NEJM198208053070617. [DOI] [PubMed] [Google Scholar]
  24. WHITNEY R. J. The measurement of volume changes in human limbs. J Physiol. 1953 Jul;121(1):1–27. doi: 10.1113/jphysiol.1953.sp004926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Weber P. C., Siess W. Interactions of renal prostaglandins with the renin-angiotensin system. Pharmacol Ther. 1981;15(2):321–337. doi: 10.1016/0163-7258(81)90048-6. [DOI] [PubMed] [Google Scholar]
  26. Williams T. D., Carter D. A., Lightman S. L. Sexual dimorphism in the posterior pituitary response to stress in the rat. Endocrinology. 1985 Feb;116(2):738–740. doi: 10.1210/endo-116-2-738. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES